.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
https://grassfed.us/Gonzoles-brother-of-Menapace-from-Warmbttel
.